Hnbadger: The pps will soon give itself over to th
Post# of 30028
1) LymPro Launch
2) Two MANF orphans
3) Eltoprazine Phase 2b trial start
4) Up listing to NASDAQ
I think the MANF data coupled with the LP002 data will bolster the pps. Will it pop us to .20 cents right away? I doubt it. But breaking that .20 cent level will I think act as a magnet on our pps over the next 2 or 3 months. It is inevitable!